You are here

Clinical Trials: Eye Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, April 9, 2020 - 12:00
Condition:   Age-Related Macular Degeneration
Intervention:   Combination Product: iPSC-derived RPE/PLGA transplantation
Sponsor:   National Eye Institute (NEI)
Recruiting
Posted: Tuesday, February 25, 2020 - 12:00
Condition:   Retinitis Pigmentosa
Intervention:   Biological: CNS10-NPC implantation
Sponsors:   Cedars-Sinai Medical Center;   California Institute for Regenerative Medicine (CIRM)
Recruiting
Posted: Monday, December 30, 2019 - 12:00
Condition:   Dry Eye
Intervention:   Drug: Umbilical Mesenchymal Stem Cells derived Exosomes
Sponsor:   Zhongshan Ophthalmic Center, Sun Yat-sen University
Not yet recruiting
Posted: Tuesday, June 11, 2019 - 12:00
Condition:   Central Retinal Vein Occlusion
Interventions:   Biological: Autologous Bone Marrow CD34+ Stem Cells;   Biological: Sham Therapy
Sponsors:   The Emmes Company, LLC;   National Eye Institute (NEI);   University of California, Davis
Not yet recruiting
Posted: Friday, May 24, 2019 - 12:00
Condition:   Retinitis Pigmentosa
Intervention:   Biological: Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)
Sponsor:   Centre d'Etude des Cellules Souches
Not yet recruiting
Posted: Thursday, May 9, 2019 - 12:00
Condition:   Retinitis Pigmentosa
Intervention:   Biological: Retinal pigment epitheliums transplantation
Sponsors:   Qi Zhou;   Beijing Tongren Hospital
Recruiting
Posted: Monday, March 18, 2019 - 12:00
Conditions:   Dry Eye;   Kerato Conjunctivitis Sicca;   Aqueous Tear Deficiency
Intervention:   Drug: Adipose tissue-derived mesenchymal stem cells
Sponsor:   Rigshospitalet, Denmark
Not yet recruiting
Posted: Tuesday, October 30, 2018 - 12:00
Conditions:   Alzheimer Disease;   Alzheimer Dementia;   Vascular Dementia;   Lewy Body Disease;   Lewy Body Dementia With Behavioral Disturbance (Disorder);   Dementia, Mixed;   Parkinson-Dementia Syndrome;   Chronic Traumatic Encephalopathy;   Huntington's Dementia;   Wernicke Korsakoff Syndrome;   Traumatic Brain Injury;   Dementia, Multi-Infarct;   Autism;   Autism Spectrum Disorder;   Autistic Behavior;   Autistic Disorder, Current or Active State
Interventions:   Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction;   Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction;   Procedure: Near Infrared Light
Sponsor:   MD Stem Cells
Recruiting
Posted: Monday, February 19, 2018 - 12:00
Condition:   Macular Holes
Intervention:   Biological: exosomes derived from mesenchymal stem cells (MSC-Exo)
Sponsor:   Tianjin Medical University
Recruiting
Posted: Tuesday, January 23, 2018 - 12:00
Conditions:   Ocular Discomfort;   Ocular Inflammation;   Dry Eye;   Contact Lens Complication;   Keratoconjunctivitis Sicca
Intervention:   Drug: Lifitegrast
Sponsors:   University of Alabama at Birmingham;   Shire
Not yet recruiting

Pages